Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms
Cariprazine is more effective than risperidone for persistent negative symptoms in schizophrenia and appears to be effective in patients resistant to previous treatment with other antipsychotic agents.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news
How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® ) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news
First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk
A recently approved first-in-class antipsychotic appears to have fewer adverse cardiometabolic effects compared with placebo or standard care with risperidone, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 3, 2020 Category: Neurology Tags: Psychiatry News Source Type: news
CHMP Backs Generic Paliperidone for Schizophrenia CHMP Backs Generic Paliperidone for Schizophrenia
Paliperidone Janssen-Cilag International, a generic of Xeplion, is for maintenance treatment of schizophrenia in adults stabilized with paliperidone or risperidone and select other cases.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 2, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news
How Aripiprazole's Promise for Treating Autism Fell Short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade's worth of data suggests that is not true. (Source: The Scientist)
Source: The Scientist - February 27, 2020 Category: Science Tags: News & Opinion Source Type: news
Perseris (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 18, 2020 Category: Drugs & Pharmacology Source Type: news
Stepped treatment for attention-deficit/hyperactivity disorder and aggressive behavior: a randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization - Blader JC, Pliszka SR, Kafantaris V, Foley CA, Carlson GA, Crowell JA, Bailey BY, Sauder C, Daviss WB, Sinha C, Matthews TL, Margulies DM.
OBJECTIVE: Stimulant medications are the most prevalent first-line pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD), but children with aggressive behavior often receive multi-agent treatment. There is sparse evidence for the benefits of ... (Source: SafetyLit)
Source: SafetyLit - February 4, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Risperidone for psychosis-induced aggression or agitation - Scruth E.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - August 8, 2019 Category: International Medicine & Public Health Tags: Commentary Source Type: news
Delayed-onset toxicity in an adolescent case following attempted suicide with an overdose of paliperidone intake - Yaylac ı F, Küçük Ö, Erkuran HO.
Paliperidone is a relatively novel atypical antipsychotic drug that is currently used to treat schizophrenia in adolescents and adults. The drug was generated by combining the active metabolite of risperidone, 9-hydroxyrisperidone, with osmotic controlled-... (Source: SafetyLit)
Source: SafetyLit - July 18, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
DURECT Appoints Two New Board Members
CUPERTINO, Calif., April 25, 2019 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) announced today the appointment of two new members to its board of directors. Dr. Gail M. Farfel, Executive Vice President and Chief Developm... Biopharmaceuticals, Drug Delivery, Personnel DURECT, PERSERIS, risperidone, Schizophrenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2019 Category: Pharmaceuticals Source Type: news
Clozapine in the treatment of aggression in conduct disorder in children and adolescents: a randomized, double-blind, controlled trial - Ju árez-Treviño M, Esquivel AC, Isida LML, Delgado DÁG, de la O Cavazos ME, Ocañas LG, Sepúlveda RS.
This study was conducted to compare the efficacy of clozapine vs. risperidone in the treatment of aggression in conduct disorder in children and adolescents. METHODS: Twenty-four children with conduct disorder aged 6 to 16 years were ran... (Source: SafetyLit)
Source: SafetyLit - January 30, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Dopamine modulates the reward experiences elicited by music
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from IDIBELL-UB, the Sant Pau Hospital and the McGill University published a new study in PNAS that shows for the first time a causal link between the dopaminergic system and enjoying music. Dopamine precursor levodopa increased the musical pleasure and music-related motivational responses, such as willingness to purchase a song, while the dopamine antagonist risperidone led to a reduction of both. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2019 Category: International Medicine & Public Health Source Type: news
Dopamine modulates reward experiences elicited by music
(University of Barcelona) New study in Proceedings of the National Academy of Science reveals causal link between dopamine and human reward response to music listening. Researchers pharmacologically manipulated dopaminergic transmission of 27 participants while listening to music and showed causal link between dopamine and pleasure. While levodopa increased hedonic experience and motivation, risperidone led to a reduction of both. These results shed light on neurobiology and neurochemistry underpinning reward responses, contributing to an open debate on human pleasures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2019 Category: International Medicine & Public Health Source Type: news
Commercial Launch Plans Announced for PERSERIS(TM) (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Indivior PLC Announces Plan for Commercial Launch in February 2019 with 50 Sales Representatives
CUPERTINO, Calif., Dec. 19, 2018 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced that Indivior PLC (LON: IND... Biopharmaceuticals, Product Launch DURECT, PERSERIS, risperidone, Schizophrenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2018 Category: Pharmaceuticals Source Type: news
risperidone, Risperdal; Risperdal Consta, Risperdal M-TAB
Title: risperidone, Risperdal; Risperdal Consta, Risperdal M-TABCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/7/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 7, 2018 Category: Drugs & Pharmacology Source Type: news
